ChoKB inhibitors are a class of chemicals that can modulate the activity of choline/ethanolamine kinase (ChoKB), a key enzyme involved in phospholipid metabolism. ChoKB catalyzes the first step of phosphatidylethanolamine and phosphatidylcholine biosynthesis. Several chemicals have been identified as inhibitors of ChoKB, either directly or indirectly affecting its activity. Hemicholinium-3 is a competitive inhibitor ofthe high-affinity choline transporter, reducing the availability of choline for phosphatidylcholine biosynthesis. Ethanolamine acts as a substrate competitor, competing with choline for the active site of ChoKB and reducing the rate of phospholipid biosynthesis. Phosphorylcholine, on the other hand, acts as a product inhibitor, binding to the active site of ChoKB and preventing further catalysis. Other inhibitors, such as PDMP and D609, target enzymes involved in sphingolipid metabolism and phospholipid metabolism, respectively. These inhibitors indirectly disrupt ChoKB activity by affecting the overall lipid metabolism pathways. U18666A, a cholesterol transport inhibitor, can also indirectly inhibit ChoKB by disrupting lipid homeostasis.
Fentin chloride and oxotremorine-M modulate cholinergic signaling pathways, indirectly influencing ChoKB activity and phospholipid biosynthesis. N,N-Dimethylsphingosine inhibits sphingosine kinase, impacting sphingolipid metabolism and indirectly affecting ChoKB. Dihydroethidium can evaluate the impact of oxidative stress on ChoKB activity, while MAFP inhibits phospholipase A2, an enzyme involved in phospholipid metabolism. Lastly, GW4869 inhibits neutral sphingomyelinase, another enzyme involved in sphingolipid metabolism, indirectly affecting ChoKB and phospholipid biosynthesis. Overall, ChoKB inhibitors encompass a range of chemicals that directly or indirectly modulate the activity of ChoKB, influencing phosphatidylethanolamine and phosphatidylcholine biosynthesis and, consequently, phospholipid metabolism. These inhibitors provide valuable tools for studying the role of ChoKB in cellular processes and may have potential applications in various research areas.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Hemicholinium-3 | 312-45-8 | sc-252873 sc-252873A | 100 mg 500 mg | $84.00 $413.00 | ||
Hemicholinium-3 is a competitive inhibitor of the high-affinity choline transporter (CHT), which is responsible for choline uptake into cells. By blocking choline uptake, it can indirectly inhibit ChoKB by reducing the availability of choline for phosphatidylcholine biosynthesis. | ||||||
Ethanolamine | 141-43-5 | sc-203042 sc-203042A sc-203042B | 25 ml 500 ml 2.5 L | $22.00 $56.00 $204.00 | 1 | |
Ethanolamine can inhibit ChoKB by acting as a substrate competitor. It can compete with choline for the active site of ChoKB, reducing the rate of phosphatidylethanolamine and phosphatidylcholine biosynthesis. | ||||||
D609 | 83373-60-8 | sc-201403 sc-201403A | 5 mg 25 mg | $189.00 $575.00 | 7 | |
D609 is an inhibitor of phosphatidylcholine-specific phospholipase C (PC-PLC), an enzyme involved in phospholipid metabolism. By inhibiting PC-PLC, D609 can indirectly inhibit ChoKB and the biosynthesis of phosphatidylcholine. | ||||||
Oxotremorine M | 63939-65-1 | sc-203656 | 100 mg | $148.00 | 3 | |
Oxotremorine-M is a muscarinic receptor agonist that can activate cholinergic signaling pathways. By modulating cholinergic signaling, it can indirectly influence ChoKB activity and phospholipid biosynthesis. | ||||||
MAFP | 188404-10-6 | sc-203440 | 5 mg | $219.00 | 4 | |
MAFP (Methyl arachidonyl fluorophosphonate) is an inhibitor of phospholipase A2 (PLA2), an enzyme involved in phospholipid metabolism. By inhibiting PLA2, MAFP can indirectly inhibit ChoKB and the biosynthesis of phosphatidylethanolamine and phosphatidylcholine. | ||||||
GW4869 | 6823-69-4 | sc-218578 sc-218578A | 5 mg 25 mg | $203.00 $611.00 | 24 | |
GW4869 inhibits neutral sphingomyelinase (nSMase), an enzyme involved in sphingolipid metabolism. By inhibiting nSMase, GW4869 can indirectly inhibit ChoKB and the biosynthesis of phospholipids. | ||||||